查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085104

生技藥品安全檢測市場：依給藥途徑、檢測類型、劑型、應用及最終用戶分類－2026-2032年全球市場預測

Biologics Safety Testing Market by Offering, Test Type, Form, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生技藥品安全檢測市場將成長至 100.9 億美元，複合年成長率為 11.03%。

主要市場統計數據
基準年 2025 48.5億美元
預計年份：2026年 53.7億美元
預測年份 2032 100.9億美元
複合年成長率 (%) 11.03%

生技藥品安全檢測市場概覽

生技藥品的安全性檢測是單株抗體、重組蛋白、疫苗、生物相似藥、細胞療法、基因療法和其他複雜生物製藥產品品管和法規遵循的關鍵環節。此領域包括無菌檢測、內毒素檢測、黴漿菌檢測、病毒安全性檢測、外來性病原體檢測、細胞株鑑定、殘留宿主細胞蛋白和DNA分析、生物微生物附著量檢測以及產品特異性效力和雜質評估。

生技藥品安全性測試的變革性變化

生技藥品安全性檢測方法正從終點品管轉向貫穿研發、生產和運輸全過程的綜合污染控制。快速微生物學方法、分子檢測、次世代定序、自動化樣品處理和電子實驗室工作流程正擴大與藥典檢測相結合，以提高檢測速度、靈敏度和質量，同時保持監管要求的可比性。

人工智慧對生技藥品安全性測試的累積影響

人工智慧 (AI) 正透過預測性污染監測、環境監測資料異常檢測、批次記錄自動審核以及更聰明的檢測方法開發，逐步影響生技藥品的安全性檢測。在高通量實驗室中，AI 驅動的分析能夠對無菌性、微生物附著量、內毒素、病毒安全性和黴漿菌等資料集進行趨勢分析，幫助品管團隊及早發現偏差並確定調查的優先順序。

全球生技藥品安全性測試的關鍵區域見解

北美仍然是生物製藥安全檢測的重要中心，這得益於其聚集的生物製藥創新公司、受FDA監管的製造地、先進療法開發公司、學術轉化研究中心以及專業的合約檢測實驗室。該地區受益於成熟的GMP檢查體系、廣泛的生物製藥臨床開發以及在無菌性、內毒素、黴漿菌和病毒安全性檢測中積極採用檢驗的快速檢測方法。歐洲的情況也類似，擁有EMA的監管、強大的國家監管機構、《歐洲藥典》以及德國、法國、義大利、西班牙和英國龐大的生技藥品和生物相似藥生產基地。監管重點在於等效性、污染控制策略和藥典合規性。

生技藥品安全性檢測需求的關鍵群體分析

東協正崛起為製造和臨床開發中心，新加坡和區域中心為生物製程、分析服務、監管可靠性途徑以及生物製藥和疫苗供應鏈的韌性提供支援。海灣合作理事會（GCC）優先考慮醫療保健多元化、生命科學投資和加強本地製藥能力，從而催生了對生物製藥、生物相似藥和疫苗的GMP檢測夥伴關係、技術轉移、實驗室合格和監管合規準備等方面的需求。

主要國家生技藥品安全性測試趨勢

美國在先進生技藥品、細胞和基因療法、FDA監管的生產以及外包生物安全檢測能力方面處於主導地位，對病毒安全性、無菌性、內毒素、黴漿菌和裝運前檢測服務的需求強勁。加拿大支持臨床研究、疫苗開發能力、受監管的生技藥品生產以及符合國際GMP標準的品質系統。墨西哥正在加強其在拉丁美洲藥品生產和監管現代化方面的作用，而巴西在疫苗、生物相似藥、公共衛生採購和生技藥品品質基礎設施方面具有強大的區域影響力。

針對負責生技藥品安全測試人員的實用建議

供應商應制定與產品整個生命週期相符的生物製藥安全測試策略，從原料合格、細胞基材特性、病毒風險評估、污染控制計畫和檢測方法適用性評估入手。申辦方應選擇擁有成熟的GMP體系、經驗證的檢測方法、全球法規遵從經驗、強大的資料完整性管理能力以及處理緊急出貨前測試能力的合作夥伴，尤其對於先進療法、個人化醫療和保存期限短的產品而言更是如此。

生技藥品安全性測試與分析的調查方法

本執行摘要是基於對檢驗的法規結構、藥典要求、公共機構指南、行業標準以及生物製藥生產趨勢的系統性回顧。分析考慮了符合FDA、EMA、ICH、USP、歐洲藥典、WHO、PIC/S和OECD原則的相關內容，包括無菌性、內毒素、黴漿菌、病毒安全性、外來性物質檢測、細胞基材表徵和GMP品質系統。

結論：生物製藥安全性測試的策略性展望

隨著產品日益複雜、生產網路日益全球化，以及監管機構對污染控制、驗證性檢測方法和資料完整性的要求不斷提高，生技藥品的安全性檢測正變得日益重要。這項市場需求持續成長，主要源自於市售生技藥品和新一代療法中病毒安全性檢測、無菌性檢測、黴漿菌檢測、細胞株鑑定、殘留雜質分析以及先進分子檢測的持續需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：生技藥品安全檢測市場：依產品/服務分類

  • 裝置
    • 內毒素領導者
    • PCR系統
    • 培養箱
  • 試劑和試劑盒
  • 服務
    • 執行
    • 維護和支援
  • 解決方案
    • LIMS/QMS整合
    • 檢測分析
    • 趨勢監測

第8章：生技藥品安全檢測市場：依檢測類型分類

  • 外來性檢測
  • 微生物附著量測試
  • 細胞株的真實性驗證和表徵
  • 內毒素試驗
  • 黴漿菌檢測
  • 殘留宿主細胞蛋白（HCP）檢測
  • 無菌測試

第9章：生技藥品安全偵測市場：依形式分類

  • 套件形式
  • 單管瓶試劑規格

第10章：生技藥品安全偵測市場：依應用領域分類

  • 基因治療
  • 單株抗體的生產
  • 重組蛋白療法
  • 幹細胞研究
  • 組織工程
  • 疫苗研發

第11章：生技藥品安全檢測市場：依最終用戶分類

  • 學術研究機構
  • 受託研究機構（CRO）
  • 製藥和生物技術公司

第12章：生技藥品安全檢測市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：生技藥品安全偵測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：生技藥品安全檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agilent Technologies, Inc.
  • Associates of Cape Cod, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Bionique Testing Laboratories
  • Catalent Inc.
  • Charles River Laboratories International, Inc.
  • Clean Biologics SAS
  • Danaher Corporation
  • Eurofins Scientific SE
  • FUJIFILM Corporation
  • GenScript Biotech Corporation
  • Intertek Group plc
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • Merck KGaA
  • Pace Analytical Services, LLC
  • Promega Corporation
  • QIAGEN NV
  • QPS Holdings LLC
  • Samsung Biologics Co., Ltd.
  • SGS SA
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • Toxikon Corporation
  • WuXi AppTec Co., Ltd.
Product Code: MRR-437D4595795B

The Biologics Safety Testing Market is projected to grow by USD 10.09 billion at a CAGR of 11.03% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.85 billion
Estimated Year [2026] USD 5.37 billion
Forecast Year [2032] USD 10.09 billion
CAGR (%) 11.03%

Biologics Safety Testing Market Introduction

Biologics safety testing is a mission-critical quality and regulatory function for monoclonal antibodies, recombinant proteins, vaccines, biosimilars, cell therapies, gene therapies, and other complex biopharmaceutical products. The field covers sterility testing, endotoxin testing, mycoplasma testing, viral safety testing, adventitious agent detection, cell line characterization, residual host cell protein and DNA analysis, bioburden testing, and product-specific potency and impurity assessments.

Demand is being reinforced by the global expansion of biologics pipelines, higher biosimilar development activity, and the scale-up of advanced therapies that require risk-based, product-specific biosafety strategies. Regulatory expectations from FDA, EMA, ICH, USP, Ph. Eur., and WHO continue to emphasize validated methods, GMP-aligned documentation, contamination control, data integrity, and lifecycle management, making biologics safety testing a core enabler of product approval, batch release, and patient protection.

Transformative Shifts in the Biologics Safety Testing Landscape

The biologics safety testing landscape is shifting from end-point quality control toward integrated contamination control across development, manufacturing, and release. Rapid microbiological methods, molecular assays, next-generation sequencing, automated sample handling, and electronic laboratory workflows are increasingly used alongside compendial tests to improve speed, sensitivity, and investigation quality while maintaining regulatory comparability.

Cell and gene therapies are accelerating this transformation because they often involve short shelf lives, small batch sizes, autologous workflows, viral vectors, complex raw materials, and limited opportunities for extended release testing. At the same time, global outsourcing to specialized CROs, CDMOs, and contract testing laboratories is expanding as sponsors seek validated platforms, biosafety expertise, surge capacity, and integrated support for viral clearance, adventitious virus testing, mycoplasma testing, and GMP release testing.

Cumulative Impact of Artificial Intelligence on Biologics Safety Testing

Artificial intelligence is beginning to influence biologics safety testing through predictive contamination monitoring, anomaly detection in environmental monitoring data, automated review of batch records, and smarter assay development. In high-throughput laboratories, AI-enabled analytics can support trend analysis across sterility, bioburden, endotoxin, viral safety, and mycoplasma datasets, helping quality teams identify deviations earlier and prioritize investigations.

The cumulative impact is operational rather than speculative: AI can reduce manual review burden, improve data integrity checks, support method optimization, and strengthen risk-based quality management when validated within GMP expectations. Adoption remains governed by requirements for explainability, audit trails, cybersecurity, human oversight, and computer system validation, particularly where AI outputs inform release decisions, deviation management, or regulatory submissions.

Key Regional Insights Across Global Biologics Safety Testing

North America remains a leading biologics safety testing hub due to the concentration of biopharmaceutical innovators, FDA-regulated manufacturing, advanced therapy developers, academic translational centers, and specialized contract testing laboratories. The region benefits from mature GMP inspection systems, extensive biologics clinical development, and strong adoption of validated rapid methods for sterility, endotoxin, mycoplasma, and viral safety testing. Europe is similarly mature, supported by EMA oversight, strong national regulatory agencies, the European Pharmacopoeia, and extensive biologics and biosimilar manufacturing across Germany, France, Italy, Spain, and the United Kingdom, with regulatory emphasis on comparability, contamination control strategy, and pharmacopoeial compliance.

Asia-Pacific is one of the most dynamic regions, driven by biologics capacity expansion in China, India, Japan, South Korea, Australia, and ASEAN markets, alongside government support for domestic vaccine production, biosimilars, and advanced therapy development. Latin America is gaining relevance through vaccine production, biosimilar commercialization, public health procurement, and regulatory convergence led by Brazil and Mexico. The Middle East is investing in biomanufacturing localization, healthcare security, and technology transfer programs that increase demand for GMP-aligned safety testing. Africa is building vaccine and biologics quality infrastructure through regional manufacturing initiatives, regulatory strengthening, and international partnerships focused on local production resilience and biologics quality assurance.

Key Group Insights for Biologics Safety Testing Demand

ASEAN is emerging as a manufacturing and clinical development corridor, with Singapore and regional hubs supporting bioprocessing, analytical services, regulatory reliance pathways, and supply chain resilience for biologics and vaccines. The GCC is prioritizing healthcare diversification, life sciences investment, and local pharmaceutical capability, creating demand for GMP testing partnerships, technology transfer, laboratory qualification, and regulatory readiness for biologics, biosimilars, and vaccines.

The European Union benefits from harmonized rules, established pharmacopoeial standards, centralized regulatory procedures, and strong biosimilar experience, making it a reference market for compliance-led safety testing. BRICS countries are central to future development activity because China, India, and Brazil combine large patient populations with expanding biologics manufacturing, while Russia and South Africa maintain policy-driven interest in domestic biologics and vaccine capabilities. G7 markets remain technology leaders in advanced testing platforms, digital quality systems, cell and gene therapy oversight, and high-complexity analytical validation. NATO-aligned countries emphasize secure supply chains, pandemic preparedness, regulatory interoperability, and resilient biopharmaceutical quality systems, reinforcing the role of biologics safety testing in national health security.

Key Country Insights in Biologics Safety Testing

The United States leads in advanced biologics, cell and gene therapy development, FDA-regulated manufacturing, and outsourced biosafety testing capacity, with strong demand for viral safety, sterility, endotoxin, mycoplasma, and release testing services. Canada supports clinical research, vaccine capabilities, regulated biologics manufacturing, and quality systems aligned with international GMP expectations. Mexico is strengthening its role in Latin American pharmaceutical manufacturing and regulatory modernization, while Brazil holds strong regional influence in vaccines, biosimilars, public health procurement, and biologics quality infrastructure.

In Europe, the United Kingdom, Germany, France, Italy, and Spain offer strong regulatory, manufacturing, and clinical trial ecosystems, with Germany and France anchored by advanced bioprocessing capabilities, Italy and Spain supported by established pharmaceutical production networks, and the United Kingdom reinforced by translational research and advanced therapy development. Russia maintains domestic biologics and vaccine capabilities shaped by local policy priorities and supply security objectives. China and India are expanding rapidly through biosimilars, recombinant products, vaccines, CDMO services, and investments in analytical testing capacity. Japan, Australia, and South Korea contribute high-quality regulatory environments, advanced biomanufacturing, strong clinical research systems, and broad adoption of validated analytical technologies for biologics safety testing.

Actionable Recommendations for Biologics Safety Testing Leaders

Vendors should align biologics safety testing strategy with the full product lifecycle, beginning with raw material qualification, cell substrate characterization, viral risk assessment, contamination control planning, and assay suitability evaluation. Sponsors should select partners with proven GMP systems, validated assays, global regulatory experience, robust data integrity controls, and capacity for urgent release testing, especially for advanced therapies, personalized medicines, and short-shelf-life products.

Organizations should also invest in digital quality systems, laboratory information management, method lifecycle management, and risk-based validation of rapid microbiological and molecular methods. Building redundancy across qualified laboratories, harmonizing global specifications, maintaining clear comparability documentation, and engaging regulators early can reduce approval delays, strengthen supply continuity, and improve confidence in biologics safety data. Leaders should prioritize cross-functional governance among quality, regulatory, manufacturing, and analytical development teams to ensure biosafety decisions are scientifically justified and inspection-ready.

Research Methodology for Biologics Safety Testing Analysis

This executive summary is developed from a structured review of verified regulatory frameworks, pharmacopoeial requirements, public agency guidance, industry standards, and observed biopharmaceutical manufacturing trends. The analysis considers FDA, EMA, ICH, USP, Ph. Eur., WHO, PIC/S, and OECD-aligned principles where relevant to sterility, endotoxin, mycoplasma, viral safety, adventitious agent testing, cell substrate characterization, and GMP quality systems.

The methodology combines secondary research, market triangulation, segment mapping, and qualitative assessment of technology adoption across biologics, biosimilars, vaccines, and cell and gene therapies. Insights are evaluated by region, country, and strategic group to identify demand drivers, compliance pressures, outsourcing patterns, regulatory expectations, and operational priorities for biologics safety testing providers and sponsors, while avoiding unsupported market sizing, market share, or forecasting claims.

Conclusion: Strategic Outlook for Biologics Safety Testing

Biologics safety testing is becoming more strategic as products grow more complex, manufacturing networks globalize, and regulators intensify expectations for contamination control, validated methods, and data integrity. The market is supported by durable demand for viral safety testing, sterility testing, endotoxin testing, mycoplasma testing, cell line characterization, residual impurity analysis, and advanced molecular assays across commercial biologics and next-generation therapies.

Organizations that combine scientific rigor, validated technology, regulatory intelligence, and scalable laboratory operations will be best positioned to support faster development, reliable batch release, and sustained patient safety. The strongest competitive advantage will come from integrating compliance, speed, digital traceability, and predictive quality into a unified biosafety testing model that meets evolving global regulatory expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Biologics Safety Testing Market, by Offering

  • 7.1. Instruments
    • 7.1.1. Endotoxin Readers
    • 7.1.2. PCR Systems
    • 7.1.3. Incubators
  • 7.2. Reagents & Kits
  • 7.3. Services
    • 7.3.1. Implementation
    • 7.3.2. Maintenance & Support
  • 7.4. Solutions
    • 7.4.1. LIMS/QMS Integrations
    • 7.4.2. Assay Analysis
    • 7.4.3. Trend Monitoring

8. Biologics Safety Testing Market, by Test Type

  • 8.1. Adventitious Agent Detection
  • 8.2. Bioburden Testing
  • 8.3. Cell Line Authentication & Characterization
  • 8.4. Endotoxin Testing
  • 8.5. Mycoplasma Testing
  • 8.6. Residual Host Cell Protein (HCP) Testing
  • 8.7. Sterility Testing

9. Biologics Safety Testing Market, by Form

  • 9.1. Kit Format
  • 9.2. Single-vial Reagent Format

10. Biologics Safety Testing Market, by Application

  • 10.1. Gene Therapy
  • 10.2. Monoclonal Antibody Production
  • 10.3. Recombinant Protein Therapeutics
  • 10.4. Stem Cell Research
  • 10.5. Tissue Engineering
  • 10.6. Vaccine Development

11. Biologics Safety Testing Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Contract Research Organizations (CROs)
  • 11.3. Pharmaceutical & Biotechnology Companies

12. Biologics Safety Testing Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Biologics Safety Testing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biologics Safety Testing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies, Inc.
  • 16.2. Associates of Cape Cod, Inc.
  • 16.3. Becton, Dickinson and Company
  • 16.4. Bio-Rad Laboratories, Inc.
  • 16.5. bioMerieux SA
  • 16.6. Bionique Testing Laboratories
  • 16.7. Catalent Inc.
  • 16.8. Charles River Laboratories International, Inc.
  • 16.9. Clean Biologics SAS
  • 16.10. Danaher Corporation
  • 16.11. Eurofins Scientific SE
  • 16.12. FUJIFILM Corporation
  • 16.13. GenScript Biotech Corporation
  • 16.14. Intertek Group plc
  • 16.15. Laboratory Corporation of America Holdings
  • 16.16. Lonza Group AG
  • 16.17. Merck KGaA
  • 16.18. Pace Analytical Services, LLC
  • 16.19. Promega Corporation
  • 16.20. QIAGEN N.V.
  • 16.21. QPS Holdings LLC
  • 16.22. Samsung Biologics Co., Ltd.
  • 16.23. SGS SA
  • 16.24. Syngene International Limited
  • 16.25. Thermo Fisher Scientific Inc.
  • 16.26. Toxikon Corporation
  • 16.27. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICS SAFETY TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BIOLOGICS SAFETY TESTING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOTOXIN READERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOTOXIN READERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOTOXIN READERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PCR SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PCR SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PCR SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INCUBATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INCUBATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INCUBATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMPLEMENTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IMPLEMENTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LIMS/QMS INTEGRATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LIMS/QMS INTEGRATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LIMS/QMS INTEGRATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ASSAY ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ASSAY ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ASSAY ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TREND MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TREND MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TREND MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ADVENTITIOUS AGENT DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ADVENTITIOUS AGENT DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ADVENTITIOUS AGENT DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOBURDEN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOBURDEN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOBURDEN TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CELL LINE AUTHENTICATION & CHARACTERIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CELL LINE AUTHENTICATION & CHARACTERIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CELL LINE AUTHENTICATION & CHARACTERIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RESIDUAL HOST CELL PROTEIN (HCP) TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RESIDUAL HOST CELL PROTEIN (HCP) TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RESIDUAL HOST CELL PROTEIN (HCP) TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STERILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STERILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STERILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL KIT FORMAT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL KIT FORMAT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL KIT FORMAT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE-VIAL REAGENT FORMAT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE-VIAL REAGENT FORMAT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE-VIAL REAGENT FORMAT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GENE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RECOMBINANT PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RECOMBINANT PROTEIN THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RECOMBINANT PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 164. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 165. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 166. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 167. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 169. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 191. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 192. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 194. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 196. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 200. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 201. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 203. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 205. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 219. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 221. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 222. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 224. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 228. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 229. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 231. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 233. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 237. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 238. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 239. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 240. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 242. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 255. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 256. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 257. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 258. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 260. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 264. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 265. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 266. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 267. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 269. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 273. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 274. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 275. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 276. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 278. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 282. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 283. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 284. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 285. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 287. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 291. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 292. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 293. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 294. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 296. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 309. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 310. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 311. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 312. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 314. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 318. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 319. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 320. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 321. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 323. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 327. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 328. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 329. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 330. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 332. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 333. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 334. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 335. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 336. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 337. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 338. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 339. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 341. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 342. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)